SENZOLO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 6.712
EU - Europa 748
AS - Asia 531
SA - Sud America 4
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 8.004
Nazione #
US - Stati Uniti d'America 6.702
CN - Cina 376
IT - Italia 185
FI - Finlandia 162
DE - Germania 127
SE - Svezia 125
VN - Vietnam 104
GB - Regno Unito 79
IN - India 36
IE - Irlanda 16
UA - Ucraina 16
FR - Francia 12
CA - Canada 7
NL - Olanda 7
RO - Romania 6
TW - Taiwan 4
BR - Brasile 3
ES - Italia 3
GR - Grecia 3
JP - Giappone 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BE - Belgio 2
ET - Etiopia 2
HK - Hong Kong 2
MX - Messico 2
NZ - Nuova Zelanda 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CH - Svizzera 1
EC - Ecuador 1
EU - Europa 1
IQ - Iraq 1
IR - Iran 1
MA - Marocco 1
PL - Polonia 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
Totale 8.004
Città #
Fairfield 1.211
Woodbridge 698
Chandler 601
Houston 561
Ashburn 525
Ann Arbor 497
Seattle 423
Cambridge 404
Wilmington 341
San Diego 158
Princeton 133
Medford 121
Beijing 111
Dong Ket 104
Des Moines 102
Helsinki 90
Roxbury 70
Nanjing 61
Padova 51
Boardman 46
Jacksonville 42
Shenyang 26
Guangzhou 24
London 24
New York 18
Dearborn 16
Pune 15
Hebei 14
Washington 14
Munich 13
Dublin 11
Hefei 11
Jinan 11
Milan 11
Changsha 10
Kilburn 9
Redwood City 9
Tianjin 9
Chicago 8
Cologno Monzese 8
Nanchang 8
Phoenix 8
Esslingen am Neckar 7
Kunming 7
Vicenza 7
Chiswick 6
Fuzhou 6
Jiaxing 6
Zhengzhou 6
Borås 5
Kharkiv 5
Ningbo 5
Nürnberg 5
Paris 5
Rockville 5
Rome 5
Bologna 4
Dolo 4
Norwalk 4
Taipei 4
Trieste 4
Venezia 4
Lozzo Atestino 3
Shanghai 3
São Paulo 3
Tappahannock 3
Tivoli 3
Tokyo 3
Acton 2
Addis Ababa 2
Amsterdam 2
Biassono 2
Brussels 2
Central 2
Chengdu 2
Florence 2
Fremont 2
Groningen 2
Gurgaon 2
Hangzhou 2
Hounslow 2
Indiana 2
Lappeenranta 2
Las Vegas 2
Modena 2
Moosburg 2
Orange 2
Prescot 2
Rovigo 2
San Jose 2
Santa Ursula 2
Toronto 2
Venice 2
Weimar 2
Aachen 1
Adliswil 1
Ankara 1
Auckland 1
Baghdad 1
Berlin 1
Totale 6.807
Nome #
The animal naming test: An easy tool for the assessment of hepatic encephalopathy 188
Cavoportal hemitransposition associated to portoportal anastomosis for liver transplant in portomesenteric thrombosis. 156
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 156
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 141
Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy 138
18F-fluorodeoxyglucose positron emission tomography study of brain metabolism in cirrhosis: effect of liver transplantation 118
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 115
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 113
Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis? 111
Markers of acute rejection and graft acceptance in liver transplantation. 105
Short-term outcomes of pediatric liver transplant recipients after transition to Adult Healthcare Service 100
A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis 100
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 100
Normal cortical regional cerebral blood flow justifies the normal neuropsychological performance in patients with cholestatic liver disease 99
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study 99
Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis. 99
Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation 99
Whole blood rotation thromboelastometry (ROTEM®) profiles in subjects with non-neoplastic portal vein thrombosis. 98
Outcome of critically ill cirrhotic patients admitted to the ICU: The role of ACLF 96
Obliterative portal venopathy without portal hypertension: An underestimated condition 95
Interventional treatment should be incorporated in the algorithm for the management of patients with portal vein thrombosis 91
Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis 90
Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression 90
Perioperative thrombotic complications in liver transplantation 89
Orthotopic Liver Transplantation in Alcoholic Liver Disease Patients 89
Non Adherence To Medical Prescriptions In Liver Transplantation: A Prospective Longitudinal Study 89
Neuropsychological alterations in hepatitis C infection: the role of inflammation. 87
Successful pregnancy in Alagille Syndrome. 84
A Longitudinal, Prospective Study On Adherence To Medical Regimen Before and After Liver Transplantation 84
Predictors of Response To Anticoagulant Therapy For the Treatment of Portal Vein Thrombosis (pvt) In Cirrhosis Patients 83
Cyanoacrylate injection to treat recurrent bleeding from Dieulafoy's lesion. 81
USE OF ANTI-HBc POSITIVE DONORS IN LIVER TRANSPLANTATION: THE EXPERIENCE OF PADUA LIVER TRANSPLANT CENTRE 81
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation 80
Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites 79
Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features 79
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 78
Hepatitis C virus and liver transplantation: Where do we stand? 77
Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma 77
HCV eradication is not associated with drop-out due to HCC progression in patients awaiting liver transplantation: A monocentric experience 77
Who Fares Worse After Liver Transplantation? Impact of Donor and Recipient Variables on Outcome: Data from a Prospective Study. 77
Recurrent facial dyskinesias due to extrapontine myelinolysis 76
Effect of Low Molecular Weight Heparin (lmwh) On Thrombin Generation In Cirrhotic Patients At Different Stages of Liver Disease 76
Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study 76
Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis 76
New insights into the coagulopathy of liver disease and liver transplantation 75
Prioritization Tools To Predict Short and Long Term Mortality Following Liver Transplantation 75
Therapeutic approaches for portal biliopathy: A systematic review 75
Liver transplantation for viral hepatitis in 2015 74
Tips for portal vein thrombosis (pvt) in cirrhosis: Not only unblocking a pipe 73
Beneficial role of terlipressin in decompensated cirrhotics with spontaneous bacterial peritonitis 72
Acute Allograft Rejection After Liver Transplantation: Incidence, Risk Factors and Impact On Outcome 70
Management of Severe Bleeding in Liver Disease and Transplantation 70
No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma 70
Endothelial damage of the portal vein is associated with Heparin-like effect in advanced stages of cirrhosis 68
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis 68
Geotrichum capitatum Invasive Infection Early After Liver Transplant 67
Does Once-Daily Tacrolimus (Advagraf) Increase Adherence to Immunosuppressive Therapy in Liver Transplanted Patients? 66
Management of the critically ill patient with cirrhosis: A multidisciplinary perspective 66
Local prothrombotic state in portal venous system in cirrhosis 66
Antibiotic therapy for spontaneous bacterial peritonitis in acute-on-chronic liver failure: Handle with care 65
Estimation of Liver Transplant Related Survival Benefit: The Devil Is in the Details 65
Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered 65
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis: results of a randomized controlled clinical trial 64
Lack of agreement for defining 'clinical suspicion of rejection' in liver transplantation: a model to select candidates for liver biopsy. 63
Evaluation of Physician Agreement For Defining "clinical Suspicion of Rejection" In Liver Transplantation 63
Screening and treatment of portal vein thrombosis in cirrhosis 63
PERIPHERAL NK CELLS IN PATIENTS WITH HCV RECURRENCE AFTER LIVER TRANSPLANTATION DURING INTERFERON-FREE ANTIVIRAL THERAPY 61
Acute Cellular Rejection in Liver Transplanted Patients: Incidence, Risk Factors, and Impact on Outcome 60
Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension 60
Fibrosis Progression in Non Responders to Antiviral Treatment (AT) in HCV Recurrence Following Liver Transplantation (LT): An Italian Multicenter Retrospective Study 59
Long-term medical and psycho-social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease 59
Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting 58
Transjugular intrahepatic portosystemic shunt in non-cirrhotic portal hypertension related to cystic fibrosis in a lung transplant patient 58
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data 54
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection 54
Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet! 54
Self-Reported Adherence to Medical Prescriptions before and after Liver Transplantation: A Longitudinal Study 52
A Commentary on the Interplay Between Severity of Liver Disease and Bacterial Infection in Hospitalized Patients with Cirrhosis 52
Biodegradable Biliary Stents for Percutaneous Treatment of Post-liver Transplantation Refractory Benign Biliary Anastomotic Strictures 52
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study 51
The concept of Quality of Life in organ transplantation 50
Management of Portal Vein (pvt) and Splacnic Veins Thrombosis (svt) In Liver Transplantation Candidates 49
Managment of Nonneoplastic Portal Vein Thrombosis in the Setting of Liver Trasplantation: a Systematic Review 46
Effect of low molecular weight heparin (LMWH) on thrombin generation in cirrhotic patients 45
Hypnotic Hallucination of Body Heating Modifies Splanchnic Circulation: Haemodynamic and Ultrasonographic Pilot Study in Normal Volunteers 45
Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure 45
Increased thrombin generation in liver transplant recipients: does immunosuppressive therapy play a role? 44
Drug induced liver injury: from pathogenesis to liver transplantation 44
Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma 44
Veno occlusive disease: up-date on clinical menagement. 43
Management of portal hypertension severe complications 43
Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy 43
Algorithm for the management of portal vein thrombosis: a prospective study in patients with liver cirrhosis 42
Liver Fibrosis and Steatosis in Alstrom Syndrome: A Genetic Model for Metabolic Syndrome 41
Algorithm For the Management of Portal Vein Thrombosis (pvt) In Patients With Cirrhosis: A Prospective Case-control Study 39
A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation 38
Role of local endothelial alterations in the pathogenesis of portal vein thrombosis in cirrhosis 37
Machine learning in liver transplantation: a tool for some unsolved questions? 37
Effect of Low Molecular Weight Heparin (lmwh) On Thrombin Generation (tg) In Cirrhotic Patients 36
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC 36
Totale 7.426
Categoria #
all - tutte 30.490
article - articoli 29.350
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 180
Totale 60.020


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019583 0 0 0 0 0 0 0 27 5 115 236 200
2019/20201.632 176 73 40 195 166 122 168 186 183 148 133 42
2020/20211.277 71 76 110 79 63 53 58 106 162 158 137 204
2021/20221.750 61 177 218 106 72 185 103 157 67 86 157 361
2022/20231.277 240 120 37 130 228 147 19 97 153 11 86 9
2023/2024647 41 147 101 76 79 104 72 27 0 0 0 0
Totale 8.159